ICI-170809, also known as ZM-170809, is a selective serotonin 5-HT2 receptor antagonist which was under development for the treatment of major depressive disorder, arrhythmias, thrombosis, and ischemic heart disorders but was never marketed.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.